乳がん腫瘍の微環境調節におけるACKR1とc-Mycの相互作用の研究
Joyeeta Talukdar1, Arnab Nayek1, Gayatri Gogoi2
1Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Discover oncology
|August 25, 2025
まとめ
この研究では,乳がんにおけるDCL8,c- MYC,ALDH1,CHEK2との相互作用について調べています. これらの複雑な関係が腫瘍の成長と転移に影響し 新しい治療標的を潜在的に明らかにします
科学分野:
- 腫瘍学
- 分子生物学
- 免疫学
背景:
- 非典型のケモカイン受容体1 (ACKR1) は,ケモカインの誘致受容体 (DARC) とも呼ばれ,がんの進行に関与しています.
- DARCの腫瘍の成長,血管新生,転移における役割はますます認識されています.
- DARCの他の分子マーカーとの相互作用を理解することは,標的の乳がん治療に不可欠です.
研究 の 目的:
- 乳がんにおけるDARCと主要な分子マーカー (CCL8,c-MYC,ALDH1,CHEK2) の相互作用を調査する.
- これらのマーカーの集団的な影響を 解明するためです
- これらの分子相互作用に基づいて潜在的な治療標的を特定する.
主な方法:
- 乳がん組織における遺伝子とタンパク質発現パターンの分析
- DARCと選択された分子マーカーの関係を評価するための相関研究.
- 観察された相互作用の機能的意味を理解するためのバイオ情報分析.
主要な成果:
- 乳がんにおけるDARCとCCL8,c- MYC,ALDH1,CHEK2の複雑な相互作用パターンが確認されました.
- DARCとこれらのマーカーは,腫瘍の進行を促進または抑制する作用があることを示唆しています.
- 特定の発現プロファイルは腫瘍の行動の異なる側面と相関する.
結論:
- DARCとCCL8,c-MYC,ALDH1,CHEK2のような分子マーカーの相互作用は,乳がんに大きな影響を与えます.
- これらの発見は,個別化された乳がん治療のためのDARC媒介経路をターゲットにする可能性を強調しています.
- これらの複雑な相互作用に関するさらなる研究は 新しい治療戦略の道を開くかもしれません
関連する概念動画
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


